Abstract

FERNANDEZ-LAZARO, Diego; HERNANDEZ-BURGOS, Nuria; COBREROS MIELGO, Raúl  and  GARCIA-LAZARO, Sandra. Evaluation of physical activity as a therapeutic adjuvant for patients with inflammatory bowel disease: A systematic review. Invest. clín [online]. 2022, vol.63, n.3, pp.304-322.  Epub Apr 18, 2023. ISSN 0535-5133.  https://doi.org/10.54817/ic.v63n3a08.

Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC). Pharmacological treatment in IBD presents a loss of efficacy and side effects, inviting to consider alternative strategies, such as the practice of physical activity (PA), as a therapeutic adjuvant. The purpose of this review was to evaluate the effectiveness of PA interventions as a tool to increase physical fitness, and health-related quality of life (HRQoL) and improve the symptomatology in patients with CD and UC, identifying the optimal PA component. The review was performed, by searching the electronic databases Medline (PubMed), SciELO, and Cochrane Library Plus, including randomized controlled trials from the last 10 years that related to IBD and PA, until January 31, 2022. We found four studies with a total of 133 patients. The performance of PA in patients with IBD (UC and CD) increases (p>0.05) physical capacity, skeletal muscle mass, bone mineral density, and HRQoL, significantly (p<0.05) increasing mood. In addition, it significantly (p<0.05) decreases intestinal inflammation and extraintestinal manifestations. A trend of reduction (p>0.05) of fatigue, blood pressure, and microbiota restoration was observed. Moderate PA and performed regularly for a minimum of eight weeks, favors the improvement of the IBD patient at the physical, psychological, HRQoL, and symptomatology levels.

Keywords : physical activity; inflammatory bowel disease; therapeutic adjuvant; fatigue; biomarkers.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )